Sublingual formulation of riluzole

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12121609
APP PUB NO 20210038499A1
SERIAL NO

17079498

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed is sublingual administration of riluzole. In particular, a method for treating a neuropsychiatric disorder or symptom by administering a sublingual formulation of riluzole is provided. In addition, a method of relieving or reducing oral pain using the sublingual formulation of riluzole is disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BIOHAVEN THERAPEUTICS LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Berman, Robert Stonington, US 25 449
Coric, Vladimir Madison, US 44 62
Saleh, Amgad Dayton, US 3 4
Vladyka, Ronald S Somerset, US 10 47
Yu, Danny Somerville, US 17 267

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 22, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 22, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 22, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00